Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 55.45 | 38.02 |
| PEG Ratio (TTM) | 1.77 | -3.14 |
| P/S Ratio (TTM) | 19.09 | 48.59 |
| P/B Ratio (TTM) | 0.97 | 0.97 |
| P/FCF Ratio (TTM) | N/A | 12.92 |
| Price to 5YR AVG Earnings Ratio | N/A | 25.58 |
| Price to 5YR AVG FCF Ratio | N/A | 26.50 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.66% | 2.02% |
| ROE (TTM) | 1.80% | 6.45% |
| Net Profit Margin (TTM) | 34.44% | 46.84% |
| ROIC 5YR AVG | N/A | 8.52% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.56% | 596.30% | N/A |
| Revenue | -4.47% | 459.91% | N/A |
| Net Income | -9.26% | 564.05% | N/A |
| Cash Flow | N/A | N/A | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.45 | 2.19 |
| Quick Ratio (TTM) | 0.45 | 2.11 |
| D/E Ratio (TTM) | 0.02 | 0.73 |
| Interest Coverage (TTM) | -65.22 | 21.27 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 11.02 | 7.91 |
| LTL to 5YR AVG FCF | N/A | 8.98 |
| Shares Outstanding Growth 5YR AVG | N/A | -1.67% |